Volume 72, Issue 5, Pages (November 2017)

Slides:

Advertisements

Similar presentations

Volume 61, Issue 5, Pages (May 2012)

Advertisements

Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer Victor E. Chen, BS, Erin.

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 58, Issue 2, Pages (August 2010)

Volume 66, Issue 6, Pages (December 2014)

Volume 58, Issue 1, Pages (July 2010)

Volume 57, Issue 6, Pages (June 2010)

European Urology Oncology

Volume 61, Issue 5, Pages (May 2012)

Control of Prostate Cancer by Transrectal HIFU in 227 Patients

Volume 68, Issue 3, Pages (September 2015)

Volume 69, Issue 1, Pages (January 2016)

Volume 51, Issue 3, Pages (March 2007)

Volume 60, Issue 5, Pages (November 2011)

Volume 71, Issue 6, Pages e171-e172 (June 2017)

Volume 52, Issue 4, Pages (October 2007)

Volume 61, Issue 4, Pages (April 2012)

Volume 63, Issue 4, Pages (April 2013)

Volume 66, Issue 3, Pages (September 2014)

Volume 63, Issue 1, Pages (January 2013)

European Urology Oncology

Nomograms for Bladder Cancer

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 54, Issue 4, Pages (October 2008)

Volume 54, Issue 4, Pages (October 2008)

Volume 61, Issue 5, Pages (May 2012)

Volume 68, Issue 1, Pages 5-7 (July 2015)

Volume 61, Issue 4, Pages (April 2012)

Volume 69, Issue 5, Pages (May 2016)

Volume 53, Issue 4, Pages (April 2008)

Volume 67, Issue 3, Pages (March 2015)

Volume 64, Issue 5, Pages (November 2013)

Volume 68, Issue 1, Pages (July 2015)

Volume 61, Issue 6, Pages (June 2012)

Volume 69, Issue 3, Pages (March 2016)

Volume 69, Issue 4, Pages (April 2016)

Volume 64, Issue 3, Pages (September 2013)

European Urology Oncology

Volume 57, Issue 4, Pages e41-e42 (April 2010)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Volume 148, Issue 1, Pages (January 2018)

Volume 61, Issue 6, Pages (June 2012)

Volume 61, Issue 5, Pages (May 2012)

Volume 64, Issue 4, Pages (October 2013)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 66, Issue 6, Pages (December 2014)

Volume 66, Issue 6, Pages (December 2014)

Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer Xizhao Sui, MD, Wei Jiang, MD, Haiqing Chen, MD, Fan.

Volume 66, Issue 2, Pages (August 2014)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Volume 53, Issue 1, Pages (January 2008)

Volume 62, Issue 3, Pages (September 2012)

Volume 50, Issue 5, Pages (November 2006)

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA Nawar Hanna, Quoc-Dien Trinh,

Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy Matthew Mossanen, Kenneth.

Volume 74, Issue 4, Pages (October 2018)

Resection of Intraabdominal Tumors With Cavoatrial Extension Using Deep Hypothermic Circulatory Arrest Christopher Lau, MD, Padraic O’Malley, MD, Mario.

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

European Urology Oncology

Volume 75, Issue 2, Pages (February 2019)

Volume 54, Issue 1, Pages (July 2008)

Volume 52, Issue 4, Pages (October 2007)

Volume 50, Issue 6, Pages (December 2006)

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Volume 52, Issue 1, Pages (July 2007)

Michael Hsie, MD, Stefania Morbidini-Gaffney, MD, Leslie J

Volume 67, Issue 4, Pages (April 2015)

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 72, Issue 5, Pages 660-664 (November 2017) Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis Bimal Bhindi, Igor Frank, Ross J. Mason, Robert F. Tarrell, Prabin Thapa, John C. Cheville, Brian A. Costello, Lance C. Pagliaro, R. Jeffrey Karnes, R. Houston Thompson, Matthew K. Tollefson, Stephen A. Boorjian European Urology Volume 72, Issue 5, Pages 660-664 (November 2017) DOI: 10.1016/j.eururo.2017.05.016 Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 1 Kaplan Meier analyses for recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) for patients without (ypT0N0/pT0N0) and with residual urothelial carcinoma of the bladder (rUCB) at radical cystectomy (RC) following neoadjuvant chemotherapy (NAC) in comparison to pathologic stage–matched controls. European Urology 2017 72, 660-664DOI: (10.1016/j.eururo.2017.05.016) Copyright © 2017 European Association of Urology Terms and Conditions